Circadian mechanisms in the regulation of melatonin synthesis: disruption with light at night and the pathophysiological consequences -

In the past two decades, the results of a number of epidemiological studies have uncovered an association between excessive light exposure at night and the prevalence of cancer. Whereas the evidence supporting this link is strongest between nighttime light and female breast and male prostate cancer, the frequency of other tumor types may also be elevated. Individuals who have the highest reported increase in cancer are chronic night shift workers and flight attendants who routinely fly across numerous time zones. There are at least two obvious physiological consequences of nighttime light exposure, i.e., a reduction in circulating melatonin levels and disruption of the circadian system (chronodisruption). Both these perturbations in experimental animals aggravate tumor growth. Melatonin has a long investigative history in terms of its ability to stymie the growth of many tumor types. Likewise, in the last decade chronodisruption has been unequivocally linked to a variety of abnormal metabolic conditions including excessive tumor growth. This brief review summarizes the processes by which light after darkness onset impedes melatonin production and disturbs circadian rhythms. The survey also reviews the evidence associating the ostensible danger of excessive nighttime light pollution to cancer risk. If an elevated tumor frequency is definitively proven to be a consequence of light at night and/or chronodisruption, it seems likely that cancer will not be the exclusive pathophysiological change associated with the rampant light pollution characteristic of modern societies.

[1]  Vilhjálmur Rafnsson,et al.  Risk of breast cancer in female flight attendants: a population-based study (Iceland) , 2001, Cancer Causes & Control.

[2]  A. Cagnacci,et al.  Prolonged melatonin administration decreases nocturnal blood pressure in women. , 2005, American journal of hypertension.

[3]  S. Cos,et al.  Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. , 1998, Cancer research.

[4]  I. Zucker,et al.  Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Blask,et al.  Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. , 2002, Current topics in medicinal chemistry.

[6]  Francine Laden,et al.  Night work and breast cancer risk: a systematic review and meta-analysis. , 2005, European journal of cancer.

[7]  K. Kędziora-Kornatowska,et al.  Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients , 2009, Journal of pineal research.

[8]  F. Peyrot,et al.  Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species , 2008, Journal of pineal research.

[9]  Josep M. Guerrero,et al.  Melatonin inhibits telomerase activity in the MCF‐7 tumor cell line both in vivo and in vitro , 2003, Journal of pineal research.

[10]  G. Tosini,et al.  The role of retinal photoreceptors in the regulation of circadian rhythms , 2009, Reviews in Endocrine and Metabolic Disorders.

[11]  R. Moore,et al.  Entrainment pathways and the functional organization of the circadian system. , 1996, Progress in brain research.

[12]  M. Wasdell,et al.  Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[13]  Till Roenneberg,et al.  IS LIGHT-AT-NIGHT A HEALTH RISK FACTOR OR A HEALTH RISK PREDICTOR? , 2009, Chronobiology international.

[14]  R. Reiter,et al.  Pineal melatonin: cell biology of its synthesis and of its physiological interactions. , 1991, Endocrine reviews.

[15]  C. Alonso-González,et al.  Melatonin–estrogen interactions in breast cancer , 2005, Journal of pineal research.

[16]  R. Reiter,et al.  The circadian melatonin rhythm and its modulation: possible impact on hypertension , 2009, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[17]  Ju-Young Kim,et al.  Melatonin attenuates lipopolysaccharide‐induced acute lung inflammation in sleep‐deprived mice , 2009, Journal of pineal research.

[18]  M. Menaker,et al.  No Evidence for Extraocular Photoreceptors in the Circadian System of the Syrian Hamster , 1999, Journal of biological rhythms.

[19]  Izzo,et al.  SUPPRESSION OF MELATONIN SECRETION IN SOME BLIND PATIENTS BY EXPOSURE TO BRIGHT LIGHT , 2001 .

[20]  R. Foster,et al.  Circadian vision , 2007, Current Biology.

[21]  J. Aguzzi,et al.  Effect of photoreceptor degeneration on circadian photoreception and free-running period in the Royal College of Surgeons rat , 2007, Brain Research.

[22]  R. Reiter,et al.  Photoreceptor damage and eye pigmentation: influence on the sensitivity of rat pineal N-acetyltransferase activity and melatonin levels to light at night. , 1985, Neuroendocrinology.

[23]  I. Kloog,et al.  Light at Night Co‐distributes with Incident Breast but not Lung Cancer in the Female Population of Israel , 2008, Chronobiology international.

[24]  E. Palmer,et al.  Identification and importance of brown adipose tissue in adult humans. , 2009, The New England journal of medicine.

[25]  R. Reiter,et al.  Hyperglycemia-related pathophysiologic mechanisms and potential beneficial actions of melatonin. , 2008, Mini reviews in medicinal chemistry.

[26]  Stuart N. Peirson,et al.  Melanopsin: an exciting photopigment , 2008, Trends in Neurosciences.

[27]  F. Scheer,et al.  Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension , 2004, Hypertension.

[28]  R. Reiter,et al.  The melatonin rhythm: both a clock and a calendar , 1993, Experientia.

[29]  T. Wehr,et al.  The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod). , 1991, The Journal of clinical endocrinology and metabolism.

[30]  L. Paulis,et al.  Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind. , 2007, Physiological research.

[31]  A. Auvinen,et al.  Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study , 2002, BMJ : British Medical Journal.

[32]  Thomas C Erren,et al.  Defining chronodisruption , 2009, Journal of pineal research.

[33]  R. Reiter,et al.  Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate , 2008, Journal of pineal research.

[34]  M. Rollag,et al.  Acute effects of unilateral or bilateral superior cervical ganglionectomy on rat pineal N-acetyltransferase activity and melatonin content , 1979, Experientia.

[35]  Mark S. Rea,et al.  Light in the Built Environment: Potential role of Circadian Disruption in Endocrine Disruption and Breast Cancer , 2001, Cancer Causes & Control.

[36]  R. Kreienberg,et al.  Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach. , 2003, Neuro endocrinology letters.

[37]  S. Shiu Towards rational and evidence‐based use of melatonin in prostate cancer prevention and treatment , 2007, Journal of pineal research.

[38]  A. B. Reddy,et al.  A clockwork web: circadian timing in brain and periphery, in health and disease , 2003, Nature Reviews Neuroscience.

[39]  M. Tuzcu,et al.  Melatonin prevents gestational hyperhomocysteinemia‐associated alterations in neurobehavioral developments in rats , 2008, Journal of pineal research.

[40]  L. Rodella,et al.  Cardiovascular diseases: protective effects of melatonin , 2007, Journal of pineal research.

[41]  Tripp Frasch,et al.  Molecular Mechanisms of Melatonin Anticancer Effects , 2009, Integrative cancer therapies.

[42]  Nihal Ahmad,et al.  Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer , 2010, Journal of pineal research.

[43]  G. Tosini,et al.  Classical Photoreceptors Regulate Melanopsin mRNA Levels in the Rat Retina , 2004, The Journal of Neuroscience.

[44]  Satchidananda Panda,et al.  Melanopsin (Opn4) Requirement for Normal Light-Induced Circadian Phase Shifting , 2002, Science.

[45]  S. Pellegrino,et al.  Oxidative stress of the newborn in the pre‐ and postnatal period and the clinical utility of melatonin , 2009, Journal of pineal research.

[46]  S. Hankinson,et al.  Night Work and Risk of Breast Cancer , 2006, Epidemiology.

[47]  R. Reiter,et al.  Role of melatonin in the epigenetic regulation of breast cancer , 2009, Breast Cancer Research and Treatment.

[48]  D. Berson,et al.  Phototransduction by Retinal Ganglion Cells That Set the Circadian Clock , 2002, Science.

[49]  David E. Blask,et al.  Light During Darkness and Cancer: Relationships in Circadian Photoreception and Tumor Biology , 2006, Cancer Causes & Control.

[50]  G. Benítez-King,et al.  Melatonin modulates microfilament phenotypes in epithelial cells: implications for adhesion and inhibition of cancer cell migration. , 2009, Histology and histopathology.

[51]  T. Ohkubo,et al.  Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. , 1997, American journal of hypertension.

[52]  W. P. Hayes,et al.  A Novel Human Opsin in the Inner Retina , 2000, The Journal of Neuroscience.

[53]  R. Reiter,et al.  A generalized theory of carcinogenesis due to chronodisruption. , 2008, Neuro endocrinology letters.

[54]  D A Newsome,et al.  Light suppresses melatonin secretion in humans. , 1980, Science.

[55]  D. Blask,et al.  Light contamination during the dark phase in "photoperiodically controlled" animal rooms: effect on tumor growth and metabolism in rats. , 1997, Laboratory animal science.

[56]  Y. Wang,et al.  The effects of nocturnal life on endocrine circadian patterns in healthy adults. , 2003, Life sciences.

[57]  N. Ahmad,et al.  Melatonin in cancer management: progress and promise. , 2006, Cancer research.

[58]  J. Arendt Jet-Lag and Shift Work: (2) Therapeutic Use of Melatonin , 1999, Journal of the Royal Society of Medicine.

[59]  R. Reiter,et al.  Mechanisms of cancer inhibition by melatonin , 2004, Journal of pineal research.

[60]  Johnni Hansen,et al.  Increased Breast Cancer Risk among Women Who Work Predominantly at Night , 2001, Epidemiology.

[61]  A. Knutsson,et al.  Health disorders of shift workers. , 2003, Occupational medicine.

[62]  C. Alonso-González,et al.  Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats. , 2006, Cancer letters.

[63]  Francis Lévi,et al.  Circadian Disruption in Experimental Cancer Processes , 2009, Integrative cancer therapies.

[64]  G. Bertschy,et al.  Melatonin in treatment of chronic sleep disorders in adults with autism: a retrospective study. , 2009, Swiss medical weekly.

[65]  J. Olcese,et al.  Protection against cognitive deficits and markers of neurodegeneration by long‐term oral administration of melatonin in a transgenic model of Alzheimer disease , 2009, Journal of pineal research.

[66]  R. Reiter,et al.  Melatonin and cardiac pathophysiology , 2009 .

[67]  Ben Harder,et al.  Bright Lights, Big Cancer , 2006 .

[68]  R. Reiter,et al.  Light at night, chronodisruption, melatonin suppression, and cancer risk: a review. , 2007, Critical reviews in oncogenesis.

[69]  A. Zanoboni,et al.  Experimental hypertension in pinealectomized rats. , 1967, Life sciences.

[70]  R. Reiter,et al.  Natural and synthetic analogues of melatonin and related compounds II. Effects on plasma thyroid hormones and cholesterol levels in male Syrian hamsters , 2005, Journal of Neural Transmission.

[71]  S. Hill,et al.  Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. , 1988, Cancer research.

[72]  Franck Delaunay,et al.  Effects of Chronic Jet Lag on Tumor Progression in Mice , 2004, Cancer Research.

[73]  G. Brainard,et al.  The suppression of pineal melatonin content and N-acetyltransferase activity by different light irradiances in the Syrian hamster: a dose-response relationship. , 1983, Endocrinology.

[74]  Francis Lévi,et al.  Disruption of Circadian Coordination and Malignant Growth , 2006, Cancer Causes & Control.

[75]  J. Chuang,et al.  Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone‐induced parkinsonian rats , 2008, Journal of pineal research.

[76]  M. Dubocovich,et al.  Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. , 2005, Cancer research.

[77]  N. Zisapel,et al.  Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. , 2003, Blood pressure.

[78]  C. Chiao,et al.  Visualization of melatonin’s multiple mitochondrial levels of protection against mitochondrial Ca2+‐mediated permeability transition and beyond in rat brain astrocytes , 2010, Journal of pineal research.

[79]  G. Brainard,et al.  Action Spectrum for Melatonin Regulation in Humans: Evidence for a Novel Circadian Photoreceptor , 2001, The Journal of Neuroscience.

[80]  R. Reiter,et al.  Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines , 2009, Journal of pineal research.

[81]  Fred W. Turek,et al.  Obesity and Metabolic Syndrome in Circadian Clock Mutant Mice , 2005, Science.

[82]  R. Reiter,et al.  The role of melatonin in the immuno-neuro-psychology of mental disorders. , 2009, Recent patents on CNS drug discovery.

[83]  S. B. Peres,et al.  Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes , 2008, Journal of pineal research.

[84]  J. Borjigin,et al.  Melatonin formation in mammals: In vivo perspectives , 2009, Reviews in Endocrine and Metabolic Disorders.

[85]  S. W. Holmes,et al.  Proceedings: The effect of melatonin on pinealectomy-induced hypertension in the rat. , 1976, British journal of pharmacology.

[86]  Thomas C. Erren,et al.  Light, timing of biological rhythms, and chronodisruption in man , 2003, Naturwissenschaften.

[87]  R. Reiter,et al.  Melatonin reduces neuronal loss and cytoskeletal deterioration: implications for Psychiatry , 2013 .

[88]  J. Orava,et al.  Functional brown adipose tissue in healthy adults. , 2009, The New England journal of medicine.

[89]  Rachel Leproult,et al.  HIGHLIGHTED TOPIC Physiology and Pathophysiology of Sleep Apnea Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes , 2022 .

[90]  R. Reiter Pineal control of a seasonal reproductive rhythm in male golden hamsters exposed to natural daylight and temperature. , 1973, Endocrinology.

[91]  W. B. Quay HISTOLOGICAL STRUCTURE AND CYTOLOGY OF THE PINEAL ORGAN IN BIRDS AND MAMMALS. , 1965, Progress in brain research.

[92]  M. Menaker,et al.  Chronic jet-lag increases mortality in aged mice , 2006, Current Biology.

[93]  J. A. Kappers SURVEY OF THE INNERVATION OF THE EPIPHYSIS CEREBRI AND THE ACCESSORY PINEAL ORGANS OF VERTEBRATES. , 1965, Progress in brain research.

[94]  R. Reiter,et al.  Interrelationships of the pineal gland, the superior cervical ganglia and the photoperiod in the regulation of the endocrine systems of hamsters. , 1966, Endocrinology.

[95]  A Lewinski,et al.  Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants. , 2001, The international journal of biochemistry & cell biology.

[96]  G. Heldmaier,et al.  Melatonin stimulates Growth of Brown Adipose Tissue , 1974, Nature.

[97]  B. Rakai,et al.  Physiological responses of the circadian clock to acute light exposure at night , 2009, Reviews in Endocrine and Metabolic Disorders.

[98]  S. Campbell,et al.  Extraocular circadian phototransduction in humans. , 1998, Science.

[99]  L. Fuentes-Broto,et al.  Light-Mediated Perturbations of Circadian Timing and Cancer Risk: A Mechanistic Analysis , 2009, Integrative cancer therapies.

[100]  R. Reiter The melatonin message: duration versus coincidence hypotheses. , 1987, Life sciences.

[101]  C S Pittendrigh,et al.  Temporal organization: reflections of a Darwinian clock-watcher. , 1993, Annual review of physiology.

[102]  Yoshiyuki Watanabe,et al.  Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. , 2006, American journal of epidemiology.

[103]  Kurt Straif,et al.  Carcinogenicity of shift-work, painting, and fire-fighting. , 2007, The Lancet. Oncology.

[104]  R. Reiter,et al.  Melatonin: The chemical expression of darkness , 1991, Molecular and Cellular Endocrinology.

[105]  Patricia A. Wood,et al.  Clock Genes and Cancer , 2009, Integrative cancer therapies.

[106]  Elmar Peschke,et al.  Melatonin, endocrine pancreas and diabetes , 2007, Journal of pineal research.

[107]  D. Blask,et al.  Putting cancer to sleep at night , 2005, Endocrine.

[108]  D. Hazlerigg,et al.  Characterizing a Mammalian Circannual Pacemaker , 2006, Science.

[109]  R. Reiter,et al.  Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin , 2009, Critical reviews in biochemistry and molecular biology.

[110]  G. Jean-Louis,et al.  No Melatonin Suppression by Illumination of Popliteal Fossae or Eyelids , 2000, Journal of biological rhythms.

[111]  J. A. Kappers The mammalian pineal organ. , 1969, Journal of neuro-visceral relations.